Bringing clarity to margin status when it matters most.Bringingclarity tomarginstatus
whenit mattersmost.
See the full picture with PerimeterSeethefullpicture with Perimeter.
See the full picture with Perimeter.
Groundbreaking Margin Visualization
Perimeter OCT Technology
Harnessing the power of advanced technology and intuitive functionality, Perimeter Medical Imaging is driven to transform cancer surgery with advanced imaging tools. The Perimeter Optical Coherence Tomography (OCT) system provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. Perimeter’s game-changing technology gives surgeons unmatched clarity and confidence on margins at the point of care.
Using light, images have 10x higher resolution than ultrasound and X‑ray and 100x higher than MRI for visualization at the cellular level.
Resolution is optimized for visualizing microscopic tissue structures down to 2mm, ideal for reviewing surgical margins.
Tissue is entirely preserved for histopathology and device does not come in contact with the patient or enter the sterile field.
Identify and annotate regions of interest with image review manipulation tools for optimized decision-making in the operating room.
Label and capture images of surgical margins on all six planes to convey accurate orientation for pathology.
In the OR, Perimeter’s technology provides ultra-high resolution visualization of my specimen in real-time. This adds to my confidence on the final margin status.
Beth DuPree, MD, FACS, ABOIM
I believe this technology represents the next standard of care in cancer surgery.
Amelia Tower, DO
New clinical research paper on the potential use of OCT for specimen imaging
This clinical paper includes new published research by renowned breast surgeon Dr. Beth B. DuPree on the potential use of OCT for real-time margin visualization.
Featured
Video
Traditional intraoperative imaging modalities do not deliver the resolution to visualize microscopic features associated with cellular-level disease. Perimeter does.
News
Perimeter announces the first commercial installation of its S-Series OCT system at a North Texas hospital.
Patient Story
Mary Leas discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Webcast Replay
Jeremy Sobotta, CEO, provides a corporate update on Perimeter's progress toward achieving key objectives, as well as commercial, clinical and product development milestones.
News
Perimeter has been named as one of the 2022 Venture 50 Companies by the TSX Venture Exchange.